Using real-world data analysis, we assist our clients to develop a coherent and strong value dossier, build a realistic economic model, and demonstrate the added value that their products or services offer to their target healthcare markets. Leveraging innovative data and technology solutions, our team will support your market access strategy and assist in developing and implementing your vision.
Stratega Optima designs, develops and provides critical review of models and support to full scale of pre and post-submission health technology assessments (HTA). As a health economics consultancy company, we are dealing with development of robust clinical and economic evidence (CEA, CBA, CUA, budget analysis, etc.) when developing an HTA submission dossier. Using real-world data analysis, we assist our clients to develop a coherent and strong value dossier, build a realistic economic model, and demonstrate the added value that their products or services offer to their target healthcare markets. In the early stages of development, we provide insights and analysis on potential market size and the design of rigorous economic evaluations. In later stages of development, we can offer more in-depth analyses to support expanded market access.
Whether you need to develop a global approach or require economic support for local market access, we will diligently plan the model specification to fit your requirements, data availability, and disease area. We also have extensive experience in securely handling and analyzing individual patient data for direct incorporation into your model, working with our statistics team as needed.
Stratega Optima specializes in developing models for early strategic planning through to reimbursement applications submission, documenting Value for Money using a range of techniques and rigorous approaches, including the development of decision analytic models, cohort models and patient-level simulations, Markov (and semi Markov) models, DES and probabilistic and deterministic methodologies and net health/net monetary benefit analyses. Our health economics and outcomes research (HEOR) services include a wide variety of offerings across the product development continuum including systematic and rapid literature review and publications in high-impact journals.
Our team will assist you in developing initiatives which constantly improve your company’s functional performance, while providing strategic direction and identifying key deliverables which will meet your budget and timelines, all the while being in alignment with your company’s requirements and values.
Our consulting solutions include:
o Burden of disease and market analysis
o Market and transaction forecasting peer review and due diligence
o Economic model conceptualization
o Disease impact modeling
o Optimizations of Investments
o Eligible patient population modeling and forecasting
o Trial-based analysis
o Health Technology Assessment (HTA) and Modeling
o Health Economic Evaluation Analysis (CEA, CEU,CBA, Budget Impact etc.) and validation
o Technical and Allocative Effectiveness Analysis
o Reimbursement, Pricing and Willingness to Pay Analysis
o Investment, cost recovery, cost allocation and pricing strategy, application and evaluation
o Economic impact, contribution and attribution studies
o Non-market valuation studies
o Multi-criteria assessment
o Value for money assessment
o Demand forecasting
o Conduct scoping and systematic reviews and research in this area